Spencer Redding

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi Inhibition of Candida albicans biofilm formation on denture material
    Spencer Redding
    Department of Dental Diagnostic Science, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 3900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:669-72. 2009
  2. ncbi Cancer therapy-related oral mucositis
    Spencer W Redding
    Department of General Dentistry, University of Texas Health Science Center Dental School, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    J Dent Educ 69:919-29. 2005
  3. ncbi Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation
    S W Redding
    Department of General Dentistry, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78229 3900, USA
    Med Mycol 42:479-81. 2004
  4. ncbi Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer
    Spencer W Redding
    Department of General Dentistry, University of Texas Health Science Center at San Antonio, South Texas Veterans Healthcare System, TX 78229 3900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:47-52. 2004
  5. ncbi Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation
    Spencer W Redding
    Department of General Dentistry, The University of Texas Health Science Center and The South Texas Veterans Healthcare System, San Antonio, Texas 78229 3900, USA
    J Clin Microbiol 41:619-22. 2003
  6. ncbi Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer
    Spencer W Redding
    Department of General Dentistry, Division of Infectious Diseases, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Microbiol 40:1879-81. 2002
  7. ncbi The role of yeasts other than Candida albicans in oropharyngeal candidiasis
    S W Redding
    Department of General Dentistry, University of Texas Health Science Center, South Texas Veterans Healthcare System, San Antonio, Texas 78229 3900, USA
    Curr Opin Infect Dis 14:673-7. 2001
  8. ncbi Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer
    S W Redding
    Department of General Dentistry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284 7881, USA
    J Clin Microbiol 37:3896-900. 1999
  9. ncbi Candida dubliniensis in radiation-induced oropharyngeal candidiasis
    S W Redding
    Department of General Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, Tex 78229 3900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:659-62. 2001
  10. ncbi Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method
    S G Revankar
    University of Texas Health Science Center at San Antonio, 78284 7881, USA
    J Clin Microbiol 36:153-6. 1998

Detail Information

Publications25

  1. ncbi Inhibition of Candida albicans biofilm formation on denture material
    Spencer Redding
    Department of Dental Diagnostic Science, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 3900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:669-72. 2009
    ..The inhibition of C. albicans biofilms on maxillary dentures could play a significant role in preventing the development of denture stomatitis...
  2. ncbi Cancer therapy-related oral mucositis
    Spencer W Redding
    Department of General Dentistry, University of Texas Health Science Center Dental School, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    J Dent Educ 69:919-29. 2005
    ..A multifaceted approach that targets the entire mucositis process will probably be needed to optimize overall prevention...
  3. ncbi Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation
    S W Redding
    Department of General Dentistry, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78229 3900, USA
    Med Mycol 42:479-81. 2004
    ..We report on a bone marrow transplant patient who developed Candida glabrata sepsis from pre-existing oral colonization...
  4. ncbi Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer
    Spencer W Redding
    Department of General Dentistry, University of Texas Health Science Center at San Antonio, South Texas Veterans Healthcare System, TX 78229 3900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:47-52. 2004
    ..As with systemic infection, previous fluconazole use appears to be a risk factor for this infection, but not with all patients...
  5. ncbi Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation
    Spencer W Redding
    Department of General Dentistry, The University of Texas Health Science Center and The South Texas Veterans Healthcare System, San Antonio, Texas 78229 3900, USA
    J Clin Microbiol 41:619-22. 2003
    ..In conclusion, development of resistance to fluconazole by C. glabrata is a highly varied process involving multiple molecular mechanisms...
  6. ncbi Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer
    Spencer W Redding
    Department of General Dentistry, Division of Infectious Diseases, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Microbiol 40:1879-81. 2002
    ....
  7. ncbi The role of yeasts other than Candida albicans in oropharyngeal candidiasis
    S W Redding
    Department of General Dentistry, University of Texas Health Science Center, South Texas Veterans Healthcare System, San Antonio, Texas 78229 3900, USA
    Curr Opin Infect Dis 14:673-7. 2001
    ..albicans as causative pathogens in oropharyngeal candidiasis both as co-infecting organisms with C. albicans and as sole pathogens themselves. Diagnosis and treatment of these emerging infections will also be discussed...
  8. ncbi Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer
    S W Redding
    Department of General Dentistry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284 7881, USA
    J Clin Microbiol 37:3896-900. 1999
    ..One patient, however, did show the acquisition of a new strain. With this high rate of infection (27%), prophylaxis to prevent infection should be evaluated for these patients...
  9. ncbi Candida dubliniensis in radiation-induced oropharyngeal candidiasis
    S W Redding
    Department of General Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, Tex 78229 3900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:659-62. 2001
    ..To our knowledge, this is the first described case of C dubliniensis contributing to oropharyngeal candidiasis in this patient population...
  10. ncbi Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method
    S G Revankar
    University of Texas Health Science Center at San Antonio, 78284 7881, USA
    J Clin Microbiol 36:153-6. 1998
    ..In addition, with isolates for which trailing endpoints are observed, reading the endpoint for the NCCLS method at 24 h may be more appropriate...
  11. ncbi In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata
    E R Oliveira
    Department of General Dentistry, University of Texas Health Science Center at San Antonio, Mail Code 7914, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Antimicrob Agents Chemother 49:3544-5. 2005
    ..Synergy was seen in 18% of all isolates and in 4% of fluconazole-resistant isolates at 48 h without evidence of antagonism. This antifungal combination may have utility against this organism...
  12. ncbi Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients
    A K Burn
    Department of General Dentistry, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
    J Clin Microbiol 42:5846-8. 2004
    ..Oral C. glabrata isolates for which the fluconazole MICs are elevated are commonly those for which the voriconazole MICs are elevated, but these increases may be transient for voriconazole, as they are for fluconazole...
  13. ncbi Isolation of non-tuberculosis mycobacteria in treated dental unit waterlines
    N B Porteous
    Department of Community Dentistry, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:40-4. 2004
    ..The purpose of the study was to investigate the presence of non-tuberculosis mycobacteria (NTM) in dental unit waterlines that were being routinely treated with an intermittent use waterline cleaner...
  14. ncbi Simple method for detecting fluconazole-resistant yeasts with chromogenic agar
    T F Patterson
    Department of Medicine, University of Texas Health Science Center at San Antonio 78284, USA
    J Clin Microbiol 34:1794-7. 1996
    ..This screening method appears to be rapid and sensitive for detection of fluconazole-resistant yeasts...
  15. ncbi Identification of Exophiala mesophila isolated from treated dental unit waterlines
    N B Porteous
    Department of Community Dentistry, University of Texas Health Science Center at San Antonio, TX 78229, USA
    J Clin Microbiol 41:3885-9. 2003
    ..This paper describes the methods used to identify Exophiala mesophila and provides salient differential features for distinguishing other mesophilic members of the genus...
  16. ncbi Oral complications in cancer chemotherapy, cancer incidence, and mortality in the U.S
    Robert A Dale
    Department of General Dentistry, University of Texas Health Science Center at San Antonio, USA
    Gen Dent 52:64-71; quiz 72. 2004
    ..The dentist is responsible for detecting and treating all active and potential sources of oral infection, in addition to providing follow-up care for the patient, in a manner that does not delay the treatment of the cancer...
  17. ncbi Antifungal susceptibility testing of micafungin against Candida glabrata isolates
    Erica R Oliveira
    Department of General Dentistry, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:457-9. 2008
    ..glabrata was performed to evaluate the hypothesis that micafungin may be a suitable alternative in treating those patients whose infections are from C. glabrata and have developed resistance to fluconazole...
  18. ncbi Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient
    Steven D Westbrook
    Department of Dental Diagnostic Sciences, The University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Med Mycol 45:187-90. 2007
    ..We report on an autologous hemopoietic stem cell transplant recipient who developed Candida krusei sepsis from pre-existing oral colonization...
  19. ncbi Isolation of an unusual fungus in treated dental unit waterlines
    Nuala B Porteous
    The University of Texas Health Science Center at San Antonio, 78229, USA
    J Am Dent Assoc 134:853-8. 2003
    ..Numerous organisms have been identified in dental unit waterlines, or DUWLs. Decontamination of DUWLs focuses on maintaining heterotrophic, mesophilic bacteria below 200 colony-forming units per milliliter as recommended by the ADA...
  20. ncbi Denture stomatitis: a role for Candida biofilms
    Gordon Ramage
    Department of Microbiology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:53-9. 2004
    ..Presence of serum and saliva conditioning films increased the initial adherence of selected isolates but had little effect in overall biofilm formation. CONCLUSIONS: Candida biofilms play a role in denture stomatitis...
  21. ncbi Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer
    Marta C Dahiya
    Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    Int J Radiat Oncol Biol Phys 57:79-83. 2003
    ..To characterize non-albicans Candida oral infections in patients with head-and-neck cancer receiving external beam radiotherapy (EBRT) with or without concurrent chemotherapy...
  22. ncbi Oral complications in radiation therapy
    Jody S Harrison
    Department of General Dentistry, University of Texas Health Science Center, San Antonio, USA
    Gen Dent 51:552-60; quiz 561. 2003
    ..This article reviews a number of these complications as well as the resources available to dentists for managing care of radiation oncology patients and improving their quality of life...
  23. ncbi Dental implants for patients who have had radiation treatment for head and neck cancer
    Jody S Harrison
    Department of General Dentistry, University of Texas Health Science Center at San Antonio, USA
    Spec Care Dentist 23:223-9. 2003
    ..Recommendations for dentists planning implant therapy for patients who have had radiation treatments are presented...
  24. ncbi Oral complications of cancer therapy
    Spencer W Redding
    University of Texas Health Science Center, Department of General Dentistry, 7703 Floyd Curl Dr, San Antonio, TX 78284, USA
    Tex Med 99:54-7. 2003
    ..A close working relationship between oncologists and dental professionals should be established to successfully manage patients undergoing cancer treatment...
  25. ncbi Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant
    Neal J Meropol
    Fox Chase Cancer Center, 7701 Burholme Ave, Philadelphia, PA 19111, USA
    J Clin Oncol 21:1452-8. 2003
    ..To evaluate the safety of recombinant human keratinocyte growth factor (KGF) when administered with fluorouracil (FU) in patients with metastatic colorectal cancer...